The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | J | Antiinfectives for systemic use | |
| 2 | J07 | Vaccines | |
| 3 | J07B | Viral vaccines | |
| 4 | J07BN | Covid-19 vaccines | |
| 5 | J07BN02 |
| Active Ingredient | Description | |
|---|---|---|
| SARS-CoV-2 spike glycoprotein (B.1 strains) |
|
|
| SARS-CoV-2 Spike glycoprotein (ChAdOx1-S) |
SARS-CoV-2 Spike glycoprotein (ChAdOx1-S) is a monovalent vaccine composed of a single recombinant, replication-deficient chimpanzee adenovirus (ChAdOx1) vector encoding the S glycoprotein of SARS-CoV-2. The SARS-CoV-2 S immunogen in the vaccine is expressed in the trimeric pre-fusion conformation; the coding sequence has not been modified in order to stabilise the expressed S-protein in the pre-fusion conformation. Following administration, the S glycoprotein of SARS-CoV-2 is expressed locally stimulating neutralising antibody and cellular immune responses, which may contribute to protection to COVID-19. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| BIMERVAX Emulsion for injection | European Medicines Agency (EU) | MPI, EU: SmPC | |
| JCOVDEN Suspension for injection | European Medicines Agency (EU) | MPI, EU: SmPC | |
| VAXZEVRIA Suspension for injection | European Medicines Agency (EU) | MPI, EU: SmPC | |
| VIDPREVTYN BETA Solution and emulsion for emulsion for injection | European Medicines Agency (EU) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
